2025 annual financial data
Keros Therapeutics 2025 Net margin
Direct answer
Net margin was 35.65%.
Operating income was 70.62M USD and net income was 87.01M USD.
Operating cash flow was 107.51M USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244.06M USD
- Operating income
- 70.62M USD
- Net income
- 87.01M USD
- Operating cash flow
- 107.51M USD